FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to clinical immunology and allergology. Method includes the preliminary preparation of autologous lymphocytes from the patient's venous blood. After this, they are activated with anti-CD3 antibodies and recombinant human interleukin-2. Then cultivate for at least 10 days. Subcutaneous administration of activated lymphocytes is initiated by the initiation course once a week for 4 weeks. Subsequent maintenance course of treatment is carried out for 6 months, carrying out one injection per month. At same time, one dose contains from 30 million to 60 million autologous activated T-lymphocytes in two milliliters of saline. Treatment is carried out simultaneously with the basic therapy with inhalants.
EFFECT: method for treating bronchial asthma is provided.
1 cl, 4 tbl, 3 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF PSEUDORHEUMATISM | 2007 |
|
RU2339385C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH ALLERGIC DISEASES BY AUTOLOGICAL LYMPHOCYTES | 2015 |
|
RU2633343C2 |
| METHOD OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2340348C1 |
| METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
| METHOD OF TREATING ALLERGIC DISEASES BY AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2395305C1 |
| METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
| METHOD OF ACHIEVING CONTROL OVER BRONCHIAL ASTHMA | 2013 |
|
RU2571894C2 |
| METHOD FOR PREVENTING EXACERBATIONS OF BRONCHIAL ASTHMA | 2003 |
|
RU2252785C1 |
| METHOD OF TREATING CHRONIC RECURRING INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINISES BY METHOD OF ENDONASAL AUTOLYMPHOCYTO THERAPY | 2009 |
|
RU2403071C1 |
| METHOD FOR REGENERATIVE TREATMENT OF PATIENTS WITH BRONCHIAL ASTHMA AND OBESITY | 2016 |
|
RU2622610C1 |
